Losartan Potassium Tablet
Product Images NDC 50090-3403
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 50090-3403). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image (Deb2d34c 8675 422d 944e E8026c82f6c2 02)
This is a comparison of two medications, Atenolol and Losartan, based on the percentage of patients with the primary endpoint. An adjusted risk reduction of 13%, with a p-value of 0.021, was observed. The study was conducted for a period of 66 months, with data collected at regular intervals of 6 months.*
Image (Deb2d34c 8675 422d 944e E8026c82f6c2 03)
Image (Deb2d34c 8675 422d 944e E8026c82f6c2 04)
This appears to be a table showing the results of a medical study comparing two drugs ("Losartan" and "Atenolol") for stroke prevention in patients who may or may not have diabetes or a history of cardiovascular disease. The table includes information about the number of patients studied, their ages and genders, and the rates of stroke (fatal/non-fatal) experienced by patients in each group. The table also provides hazard ratios and confidence intervals.*
Image (Deb2d34c 8675 422d 944e E8026c82f6c2 05)
Label Image (Lbl500903403)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.